BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.900
+0.040 (2.15%)
Aug 14, 2025, 11:51 AM - Market open
BioCardia Revenue
In the year 2024, BioCardia had annual revenue of $58.00K, down -87.84%.
Revenue (ttm)
$58.00K
Revenue Growth
-87.84%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
11.02M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 58.00K | -419.00K | -87.84% |
| Dec 31, 2023 | 477.00K | -875.00K | -64.72% |
| Dec 31, 2022 | 1.35M | 337.00K | 33.20% |
| Dec 31, 2021 | 1.02M | 870.00K | 600.00% |
| Dec 31, 2020 | 145.00K | -565.00K | -79.58% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BCDA News
- 2 days ago - BioCardia, Inc. (BCDA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 7 days ago - BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025 - GlobeNewsWire
- 10 days ago - BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter - GlobeNewsWire
- 3 months ago - BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025 - GlobeNewsWire
- 3 months ago - BioCardia, Inc. (BCDA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioCardia Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 3 months ago - BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025 - GlobeNewsWire